Pharmaron Beijing Co Ltd
SZSE:300759
Pharmaron Beijing Co Ltd
SZSE:300759
Price:
19.75 CNY
-1%
Market Closed
Updated:
May 2, 2024
Pharmaron Beijing Co Ltd
Cash from Operating Activities
|
Pharmaron Beijing Co Ltd
Cash from Operating Activities Peer Comparison
Comparables:
603259
2269
300347
M
688114
W
2268
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Operating Activities
¥2.8B
|
CAGR 3-Years
19%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Operating Activities
¥13.4B
|
CAGR 3-Years
50%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Operating Activities
¥6.8B
|
CAGR 3-Years
54%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
17%
|
CAGR 10-Years
31%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Cash from Operating Activities
¥1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Cash from Operating Activities
¥251.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pharmaron Beijing Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
2.8B
CNY
2.8B
CNY
Based on the financial report for Dec 31, 2023, Pharmaron Beijing Co Ltd's Cash from Operating Activities amounts to 2.8B CNY.
What is Pharmaron Beijing Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
28%
28%
Over the last year, the Cash from Operating Activities growth was 29%. The average annual Cash from Operating Activities growth rates for Pharmaron Beijing Co Ltd have been 19% over the past three years , 28% over the past five years .
You don't have any saved screeners yet
